
Shares in Novo Nordisk plunged 20% on Friday. Read More
Source link

rambamwellness.com > Money > Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
posted on
the authorRambamwellness.com
All posts byRambamwellness.com
Recent Comments